JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M610141200 on December 11, 2006

J. Biol. Chem., Vol. 282, Issue 6, 3507-3519, February 9, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/6/3507    most recent
M610141200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xia, D.
Right arrow Articles by Kurie, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xia, D.
Right arrow Articles by Kurie, J. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Mitogen-activated Protein Kinase Kinase-4 Promotes Cell Survival by Decreasing PTEN Expression through an NF{kappa}B-dependent Pathway*Formula

Dianren Xia{ddagger}, Harish Srinivas{ddagger}, Young-ho Ahn{ddagger}, Gautam Sethi§, Xiaoyang Sheng, W. K. Alfred Yung, Qianghua Xia||, Paul J. Chiao||, Heetae Kim**, Powel H. Brown**, Ignacio I. Wistuba{ddagger}, Bharat B. Aggarwal§, and Jonathan M. Kurie{ddagger}1

From the {ddagger}Departments of Thoracic/Head and Neck Medical Oncology, §Experimental Therapeutics, Neuro-Oncology, and ||Surgical Oncology, University of Texas M. D. Anderson Cancer Center and **Breast Center and Department of Medicine, Baylor College of Medicine, Houston, Texas 77030

Mitogen-activated protein kinase kinase-4 (MKK4/SEK1) cooperates with phosphatidylinositol 3-kinase to maintain the survival of non-small cell lung cancer (NSCLC) cells, but the biochemical basis of this phenomenon has not been elucidated. Here we used genetic approaches to modulate MKK4 expression in mouse embryo fibroblasts (MEF cells) and NSCLC cells to identify prosurvival signals downstream of MKK4. Relative to wild-type MEF cells, MKK4-null MEF cells were highly susceptible to apoptosis by LY294002, paclitaxel, or serum starvation. MKK4 promoted the survival of MEF cells by decreasing the expression of phosphatase and tensin homologue deleted from chromosome 10 (PTEN). MKK4 inhibited PTEN transcription by activating NF{kappa}B, a transcriptional suppressor of PTEN. MKK4 was required for nuclear translocation of RelA/p65 and processing of the NF{kappa}B2 precursor (p100) into the mature form (p52). Studies on a panel of NSCLC cell lines revealed a subset with high MKK4/high NF{kappa}B/low PTEN that was relatively resistant to apoptosis. Thus, MKK4 promotes cell survival by activating phosphatidylinositol 3-kinase through an NF{kappa}B/PTEN-dependent pathway.


Received for publication, October 30, 2006 , and in revised form, December 1, 2006.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. 1.

1 To whom correspondence should be addressed: University of Texas M. D. Anderson Cancer Center, Dept. of Thoracic/Head and Neck Medical Oncology-Unit 432, 1515 Holcombe Blvd., Houston, TX 77030. Tel.: 713-792-6363; Fax: 713-792-1220; E-mail: jkurie{at}mdanderson.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
M. Escriva, S. Peiro, N. Herranz, P. Villagrasa, N. Dave, B. Montserrat-Sentis, S. A. Murray, C. Franci, T. Gridley, I. Virtanen, et al.
Repression of PTEN Phosphatase by Snail1 Transcriptional Factor during Gamma Radiation-Induced Apoptosis
Mol. Cell. Biol., March 1, 2008; 28(5): 1528 - 1540.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
V. Dave, S. E. Wert, T. Tanner, A. R. Thitoff, D. E. Loudy, and J. A. Whitsett
Conditional Deletion of Pten Causes Bronchiolar Hyperplasia
Am. J. Respir. Cell Mol. Biol., March 1, 2008; 38(3): 337 - 345.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Iwanaga, Y. Yang, M. G. Raso, L. Ma, A. E. Hanna, N. Thilaganathan, S. Moghaddam, C. M. Evans, H. Li, W.-W. Cai, et al.
Pten Inactivation Accelerates Oncogenic K-ras-Initiated Tumorigenesis in a Mouse Model of Lung Cancer
Cancer Res., February 15, 2008; 68(4): 1119 - 1127.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
T. Tamguney and D. Stokoe
New insights into PTEN
J. Cell Sci., December 1, 2007; 120(23): 4071 - 4079.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Sethi, K. S. Ahn, D. Xia, J. M. Kurie, and B. B. Aggarwal
Targeted Deletion of MKK4 Gene Potentiates TNF-Induced Apoptosis through the Down-Regulation of NF-{kappa}B Activation and NF-{kappa}B-Regulated Antiapoptotic Gene Products
J. Immunol., August 1, 2007; 179(3): 1926 - 1933.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.